The status of naloxone in community pharmacies across Canada
Can Pharm J (Ott)
.
2020 Sep 21;153(6):352-356.
doi: 10.1177/1715163520958435.
eCollection 2020 Nov-Dec.
Authors
Randy So
1
2
3
4
5
6
7
8
9
,
Yazid Al Hamarneh
1
2
3
4
5
6
7
8
9
,
Mark Barnes
1
2
3
4
5
6
7
8
9
,
Michael A Beazely
1
2
3
4
5
6
7
8
9
,
Michael Boivin
1
2
3
4
5
6
7
8
9
,
Julie Laroche
1
2
3
4
5
6
7
8
9
,
Harsit Patel
1
2
3
4
5
6
7
8
9
,
Aaron Sihota
1
2
3
4
5
6
7
8
9
,
Tim Smith
1
2
3
4
5
6
7
8
9
,
Ross T Tsuyuki
1
2
3
4
5
6
7
8
9
Affiliations
1
University of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
2
RespectRx (Barnes), Ottawa, ON.
3
Faculty of Pharmacy (Beazely), University of Waterloo, Waterloo, ON.
4
CommPharm Consulting (Boivin), Barrie, ON.
5
Familiprix (Laroche), St-Lin Laurentides, QC.
6
Hamilton General Hospital (Patel), Hamilton Health Sciences Center, Hamilton, ON.
7
University of British Columbia (Sihota), Vancouver, BC.
8
Pharmacists Manitoba (Smith), Winnipeg, MB.
9
Northwest Territories Pharmacy Association (Smith), Yellowknife, NT.
PMID:
33282025
PMCID:
PMC7689620
DOI:
10.1177/1715163520958435
No abstract available